Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Proprotein Convertase Subtilisin/Kexin Type 9

• 1.1 Definition of Proprotein Convertase Subtilisin/Kexin Type 9
• 1.2 Proprotein Convertase Subtilisin/Kexin Type 9 Segment by Type
  • 1.2.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 SX-PCK9
  • 1.2.3 O-304
  • 1.2.4 K-312
  • 1.2.5 BLSM-201
  • 1.2.6 DCRPCSK-9
  • 1.2.7 Others
• 1.3 Proprotein Convertase Subtilisin/Kexin Type 9 Segment by Applications
  • 1.3.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Cardiovascular Disease
  • 1.3.3 Homozugous Familial Hyperchalesterolemia
  • 1.3.4 Liver Disease
  • 1.3.5 Metabolic Syndrome
  • 1.3.6 Others
• 1.4 Global Proprotein Convertase Subtilisin/Kexin Type 9 Overall Market
  • 1.4.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue (2014-2025)
  • 1.4.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production (2014-2025)
  • 1.4.3 North America Proprotein Convertase Subtilisin/Kexin Type 9 Status and Prospect (2014-2025)
  • 1.4.4 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Status and Prospect (2014-2025)
  • 1.4.5 China Proprotein Convertase Subtilisin/Kexin Type 9 Status and Prospect (2014-2025)
  • 1.4.6 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Status and Prospect (2014-2025)
  • 1.4.8 India Proprotein Convertase Subtilisin/Kexin Type 9 Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Proprotein Convertase Subtilisin/Kexin Type 9
• 2.3 Manufacturing Process Analysis of Proprotein Convertase Subtilisin/Kexin Type 9
• 2.4 Industry Chain Structure of Proprotein Convertase Subtilisin/Kexin Type 9

3 Development and Manufacturing Plants Analysis of Proprotein Convertase Subtilisin/Kexin Type 9

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Proprotein Convertase Subtilisin/Kexin Type 9
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Proprotein Convertase Subtilisin/Kexin Type 9 Production and Capacity Analysis
• 4.2 Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Analysis
• 4.3 Proprotein Convertase Subtilisin/Kexin Type 9 Price Analysis
• 4.4 Market Concentration Degree

5 Proprotein Convertase Subtilisin/Kexin Type 9 Regional Market Analysis

• 5.1 Proprotein Convertase Subtilisin/Kexin Type 9 Production by Regions
  • 5.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production by Regions
  • 5.1.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Regions
• 5.2 Proprotein Convertase Subtilisin/Kexin Type 9 Consumption by Regions
• 5.3 North America Proprotein Convertase Subtilisin/Kexin Type 9 Market Analysis
  • 5.3.1 North America Proprotein Convertase Subtilisin/Kexin Type 9 Production
  • 5.3.2 North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Proprotein Convertase Subtilisin/Kexin Type 9 Import and Export
• 5.4 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Analysis
  • 5.4.1 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Production
  • 5.4.2 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Import and Export
• 5.5 China Proprotein Convertase Subtilisin/Kexin Type 9 Market Analysis
  • 5.5.1 China Proprotein Convertase Subtilisin/Kexin Type 9 Production
  • 5.5.2 China Proprotein Convertase Subtilisin/Kexin Type 9 Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Proprotein Convertase Subtilisin/Kexin Type 9 Import and Export
• 5.6 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Market Analysis
  • 5.6.1 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Production
  • 5.6.2 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Import and Export
• 5.7 Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Market Analysis
  • 5.7.1 Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Production
  • 5.7.2 Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Import and Export
• 5.8 India Proprotein Convertase Subtilisin/Kexin Type 9 Market Analysis
  • 5.8.1 India Proprotein Convertase Subtilisin/Kexin Type 9 Production
  • 5.8.2 India Proprotein Convertase Subtilisin/Kexin Type 9 Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Proprotein Convertase Subtilisin/Kexin Type 9 Import and Export

6 Proprotein Convertase Subtilisin/Kexin Type 9 Segment Market Analysis (by Type)

• 6.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production by Type
• 6.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Type
• 6.3 Proprotein Convertase Subtilisin/Kexin Type 9 Price by Type

7 Proprotein Convertase Subtilisin/Kexin Type 9 Segment Market Analysis (by Application)

• 7.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption by Application
• 7.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Market Share by Application (2014-2019)

8 Proprotein Convertase Subtilisin/Kexin Type 9 Major Manufacturers Analysis

• 8.1 AFFiRiS AG
  • 8.1.1 AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
  • 8.1.2 AFFiRiS AG Product Introduction, Application and Specification
  • 8.1.3 AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Betagenon AB
  • 8.2.1 Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
  • 8.2.2 Betagenon AB Product Introduction, Application and Specification
  • 8.2.3 Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Bioleaders Corp
  • 8.3.1 Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
  • 8.3.2 Bioleaders Corp Product Introduction, Application and Specification
  • 8.3.3 Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 BioLingus AG
  • 8.4.1 BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
  • 8.4.2 BioLingus AG Product Introduction, Application and Specification
  • 8.4.3 BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Catabasis Pharmaceuticals Inc
  • 8.5.1 Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
  • 8.5.2 Catabasis Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.5.3 Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Dicerna Pharmaceuticals Inc
  • 8.6.1 Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
  • 8.6.2 Dicerna Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.6.3 Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Eli Lilly and Co
  • 8.7.1 Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
  • 8.7.2 Eli Lilly and Co Product Introduction, Application and Specification
  • 8.7.3 Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Ensemble Therapeutics Corp
  • 8.8.1 Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
  • 8.8.2 Ensemble Therapeutics Corp Product Introduction, Application and Specification
  • 8.8.3 Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Kowa Co Ltd
  • 8.9.1 Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
  • 8.9.2 Kowa Co Ltd Product Introduction, Application and Specification
  • 8.9.3 Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Novartis AG
  • 8.10.1 Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
  • 8.10.2 Novartis AG Product Introduction, Application and Specification
  • 8.10.3 Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Pfizer Inc
• 8.12 Regeneron Pharmaceuticals Inc
• 8.13 Serometrix LLC
• 8.14 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
• 8.15 The Medicines Company

9 Development Trend of Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Market

• 9.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Trend Analysis
  • 9.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Proprotein Convertase Subtilisin/Kexin Type 9 Regional Market Trend
  • 9.2.1 North America Proprotein Convertase Subtilisin/Kexin Type 9 Forecast 2019-2025
  • 9.2.2 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Forecast 2019-2025
  • 9.2.3 China Proprotein Convertase Subtilisin/Kexin Type 9 Forecast 2019-2025
  • 9.2.4 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Forecast 2019-2025
  • 9.2.5 Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Forecast 2019-2025
  • 9.2.6 India Proprotein Convertase Subtilisin/Kexin Type 9 Forecast 2019-2025
• 9.3 Proprotein Convertase Subtilisin/Kexin Type 9 Market Trend (Product Type)
• 9.4 Proprotein Convertase Subtilisin/Kexin Type 9 Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Proprotein Convertase Subtilisin/Kexin Type 9 Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List